The Canadian group brings a wealth of scientific writing expertise to IMC

" /> The Canadian group brings a wealth of scientific writing expertise to IMC

" />

Please login to the form below

Not currently logged in
Email:
Password:

Integrated Medhealth Communication group acquires Script Medical Writing

The Canadian group brings a wealth of scientific writing expertise to IMC

IMCIndependent medical communications agency Integrated Medhealth Communication (IMC) has acquired Toronto-based Script Medical Writing as part of the expansion plans for its North American office.

London-headquartered IMC is looking to the deal to boost its scientific writing expertise and talent as well as bring what it says will be a significant number of new pharmaceutical and biotech clients.

Shairose Ebrahim, founder and CEO of the IMC group, said: “I am delighted to welcome the Script team to IMC NA. This acquisition is a testament to our unprecedented growth and success in the North American market and will strengthen our position as a leader in scientific communications globally.”

Script was established in 1998 and has developed medical content including peer-reviewed journals and abstracts, posters and presentations for international congress across multiple therapy areas.

“Increasing our scientific writing expertise through Script, combined with our capabilities in developing innovative medical communications solutions, will provide added value to our clients and enable us to help them achieve greater success with their brands and communication programmes,” said Dr Azhar Rana, vice president and managing director of IMC North America.

Article by
Gemma Jones

13th July 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics